| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 02/21/2008 | CA2660994A1 Substituted acetylenic compounds useful for the treatment of diseases |
| 02/21/2008 | CA2660911A1 Thiourea compounds |
| 02/21/2008 | CA2660637A1 Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque |
| 02/21/2008 | CA2660604A1 Tetrahydrobenzothiophene derivatives |
| 02/21/2008 | CA2660555A1 Viral polymerase inhibitors |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1889617A1 Triphenyl modified 5-membered heterocycles and their use as anticancer and antiflammatory agents |
| 02/20/2008 | EP1888570A2 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof |
| 02/20/2008 | EP1888567A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors |
| 02/20/2008 | EP1888554A2 Process for the preparation of (s)-(-)-n,n-dimethyl-3-(2-thienyl)-3-hydroxypropanamine, a duloxetine intermediate |
| 02/20/2008 | EP1888553A1 Photochromic and electrochromic compounds and synthesis and use thereof |
| 02/20/2008 | EP1888532A1 Heteroaroyl-substituted serine amides |
| 02/20/2008 | EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1888058A2 Inhibitors of soluble adenylate cyclase |
| 02/20/2008 | EP1697304B1 Peroxisome proliferator activated receptor modulators |
| 02/20/2008 | CN101128493A Compound, polymer and optical component |
| 02/20/2008 | CN101128451A Derivatives of n-[(4,5-diphenyl-2-thienyl)methyl]amine, their preparations and therapeutic application |
| 02/20/2008 | CN101128450A New thiophene compound and method for producing kahweofuran or its analog using the same as raw material |
| 02/20/2008 | CN101125848A A process for preparing duloxetine and intermediates for use therein |
| 02/20/2008 | CN101125794A Polycyclic arene compound, synthetic method and use thereof |
| 02/20/2008 | CN101125138A Inhibitors against the production and release of inflammatory cytokines |
| 02/19/2008 | USRE40086 [4S-(4,12a alpha )]-4-(dimethylamino)-7-(substituted)-9-(substituted amino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12 a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamides; wide spectrum bactericides, including tetracycline-resistant strains; veterinary medicine |
| 02/19/2008 | US7332631 Fc receptor modulating compounds and compositions |
| 02/19/2008 | US7332623 Aryl-substituted acyclic enediyne compounds |
| 02/19/2008 | US7332622 Process for preparing optically active nitro compounds and cyano compounds |
| 02/19/2008 | US7332616 Polymerizable compound, polymer, positive-resist composition, and patterning process using the same |
| 02/19/2008 | US7332615 Bioavailability; acid, amine, or polyhydroxy-functionalized; e.g. mono-[1-(4,8-dioxo-4,8-dihydrobenzo[1,2-b;5,4-b']dithiophen-2-yl)-methyl]succinate; antitumor agents; non-small cell lung cancer, breast cancer, nasopharynx carcinoma and prostate cancer |
| 02/19/2008 | US7332524 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/19/2008 | US7332518 Carboxamides as fungicides in agriculture |
| 02/19/2008 | US7332516 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
| 02/19/2008 | US7332513 N-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-formamide for example; compound forms a naturally occurring metabolite when NO is released to slow or prevent drug tolerance; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 02/19/2008 | US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor |
| 02/19/2008 | CA2316310C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 02/14/2008 | WO2008019096A1 Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino}sulfonyl}-2-thiophenecarboxamide |
| 02/14/2008 | WO2008018544A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | WO2008017824A1 Bicyclo [2. 2. 1] hept-7-ylamine derivatives and their use |
| 02/14/2008 | WO2008017164A1 Thiophenecarboxamide derivatives as ep4 receptor ligands |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | US20080038276 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment |
| 02/14/2008 | CA2660424A1 Sulfonamide compound or salt thereof |
| 02/14/2008 | CA2660133A1 Thiophenecarboxamide derivatives as ep4 receptor ligands |
| 02/14/2008 | CA2659884A1 Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino}sulfonyl}-2-thiophenecarboxamide |
| 02/13/2008 | CN101124214A Process for removal of sulfur from components for blending of transportation fuels |
| 02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
| 02/13/2008 | CN101124196A Process for the preparation of enantiomerically pure 1-substituted-3-aminoalcohols |
| 02/13/2008 | CN100368394C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 02/13/2008 | CN100368392C Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation |
| 02/13/2008 | CN100368384C Method for the production of monoalkylamino ketones |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329766 Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives |
| 02/12/2008 | US7329765 Benzothiophene compounds having antiinfective activity |
| 02/12/2008 | US7329764 Substitute benzothiophene compounds |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them |
| 02/07/2008 | WO2008015517A2 Ep2 agonists |
| 02/07/2008 | WO2008015265A1 Anthracen derivatives and their use for the treatment of benign and malignant tumorous diseases |
| 02/07/2008 | WO2008015137A2 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 02/07/2008 | US20080033171 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants |
| 02/07/2008 | US20080033034 Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | DE10361713B4 Verwendung von Charge-Transfer-Komplexen aus einem Elektronendonor und einem Elektronenakzeptor als Basis für resistive Speicher und Speicherzelle enthaltend diese Komplexe Use of charge-transfer complexes made of an electron donor and an electron acceptor as the basis for memory and resistive memory cell comprising these complexes |
| 02/07/2008 | CA2659581A1 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 02/06/2008 | EP1884515A1 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 02/06/2008 | EP0773939B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 02/06/2008 | CN101119985A N-[(4,5-diphenyl-2-thienyl)methyl]sulfonamide derivatives, preparation thereof and their therapeutic application |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326731 Muscarinic agonists |
| 02/05/2008 | US7326729 CXCR1 and CXCR2 chemokine antagonists |
| 02/05/2008 | US7326695 Anti-bacterial agents based upon oxoanion binding |
| 02/05/2008 | US7326511 chemically amplified photoresist comprising compounds which cures upon the action of an acid or whose solubility is increased upon the action of an acid and photosensitive acid generators; give high resolution with good resist profile |
| 02/05/2008 | CA2449445C Fluorous triphase and other multiphase systems |
| 02/05/2008 | CA2284977C 3,3-disubstituted propylamines, their use and preparation |
| 01/31/2008 | WO2008013030A1 Compound, acid generator, resist composition and method for forming resist pattern |
| 01/31/2008 | WO2008012782A2 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 01/31/2008 | WO2007119116A3 Improved synthesis and preparations of duloxetine salts |
| 01/31/2008 | US20080027229 Compounds for the treatment of metabolic disorders |
| 01/31/2008 | US20080027228 Substituted thioacetamides |
| 01/31/2008 | US20080027128 Duloxetine HCL polymorphs |
| 01/31/2008 | US20080027109 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 01/31/2008 | US20080027096 Novel Pharmaceutical Compositions |
| 01/31/2008 | US20080027087 CB1 antagonists and inverse agonists |
| 01/31/2008 | US20080027077 Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/31/2008 | US20080027068 Heterocyclic compounds and thrombopoietin receptor activators |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080027048 2-Phenylthiophene Derivative |
| 01/31/2008 | US20080025935 Inhibition of sweat malodor |
| 01/30/2008 | EP1881961A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 01/30/2008 | EP1881958A1 Diacylglycerol acyltransferase inhibitors |
| 01/30/2008 | CN101115749A Aminopyrimidine compounds and methods of use |
| 01/30/2008 | CN101115735A Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/30/2008 | CN101115719A Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 01/30/2008 | CN101115713A HIV protease inhibitors |
| 01/30/2008 | CN101115711A Diacylglycerol acyltransferase inhibitors |
| 01/30/2008 | CN100364986C Preparation of (S-(+)-N,N-methyl-3-(1-naphthyl-oxy)-3-(2-thienyl) propylamine |
| 01/29/2008 | US7323608 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2008 | US7323587 Selective estrogen receptor modulators |